Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 1 44Phase 3 10Phase 1/2 6Phase NA 4Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Terminated 6Completed 6Active not recruiting 4Unknown 2Recruiting 2

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 2Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Sarcoma 2Urinary Bladder Neoplasms 1Solid Tumors 1Ovarian Neoplasms 1Hemangiosarcoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Islet Cell 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × pazopanib × Clear all
NCT02303028 2022-06-28

TOPAZ

The Hospital for Sick Children

Phase 1/2 Completed
30 enrolled
Other solid neoplasm

Solid Tumors

NCT01465659 2021-08-05

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Northwestern University

Phase 1/2 Completed
29 enrolled 16 charts

Carcinoma, Islet Cell

NCT01975519 2020-05-20

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Tracon Pharmaceuticals Inc.

Phase 1/2 Completed
111 enrolled 15 charts
Sarcoma

Hemangiosarcoma, Sarcoma

NCT01719302 2016-06-16

Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma

University of Vermont

Phase 1/2 Completed
6 enrolled
Sarcoma

Sarcoma

NCT01238770 2016-02-10

Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer

University Hospital Heidelberg

Phase 1/2 Completed
10 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01265940 2012-10-10

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Lukas-Krankenhaus GmbH

Phase 1/2 Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡